07-4069. National Cancer Institute; Notice of Closed Meetings  

  • Start Preamble

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

    The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Initial Review Group, Subcommittee G—Education.

    Date: September 11-12, 2007.

    Time: 8 a.m. to 4:45 p.m.

    Agenda: To review and evaluate grant applications.

    Place: Gaithersburg Marriott Washingtonian Center, 204 Boardwalk Place, Gaithersburg, MD 20878.

    Contact Person: Sonya Roberson, PhD., Scientific Review Administrator, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd., Room 8109, Bethesda, MD 20892, 301-594-1182, robersos@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis Panel, R25 Special Emphasis Panel (SEP).

    Date: September 11, 2007.

    Time: 5 p.m. to 7 p.m.

    Agenda: To review and evaluate grant applications.

    Place: Gaithersburg Marriott Washingtonian Center, 204 Boardwalk Place, Gaithersburg, MD 20878.

    Contact Person: Jeannette F. Korczak, PhD., Scientific Review Administrator, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Room 8115, Bethesda, MD 20892, 301-496-9767, korczakj@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis Panel, Oral Bioavailability Enhancement.

    Date: September 18, 2007.

    Time: 2 p.m. to 4 p.m.

    Agenda: To review and evaluate contract proposals.

    Place: National Institutes of Health, 6130 Executive Blvd., Conference Room C, Rockville, MD 20852. (Telephone Conference Call).

    Contact Person: Thomas M. Vollberg, PhD., Scientific Review Administrator, Special Review And Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd., Room 7142, Bethesda, MD 20892, 301-594-9582, vollbert@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis Panel, Clinical Studies SEP.

    Date: October 3-4, 2007.

    Time: 8 a.m. to 1 p.m.

    Agenda: To review and evaluate grant applications.

    Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814.

    Contact Person: Majed M. Hamawy, PhD., MBA, Scientific Review Administrator, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 8135, Bethesda, MD 20852, 301-496-7565, mh101v@nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis Panel, Clinical SEP 2.

    Date: October 4, 2007.

    Time: 1 p.m. to 2 p.m.

    Agenda: To review and evaluate grant applications.

    Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814.

    Contact Person: Peter J. Wirth, PhD., Scientific Review Administrator, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 8131, Bethesda, MD 20892-8328, 301-496-7565, pw2q@nih.gov.

    (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS).

    Start Signature
    Start Printed Page 46648

    Dated: August 13, 2007.

    Jennifer Spaeth,

    Director, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 07-4069 Filed 8-20-07; 8:45 am]

    BILLING CODE 4140-01-M

Document Information

Effective Date:
9/11/2007
Published:
08/21/2007
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
07-4069
Dates:
September 11-12, 2007.
Pages:
46647-46648 (2 pages)
PDF File:
07-4069.pdf